You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 27 No. 4, October 1972 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (84)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Therapeutic Approaches to Tardive Dyskinesia

A Review of the Literature

Hajime Kazamatsuri, MD; Ching-piao Chien, MD; Jonathan O. Cole, MD

Arch Gen Psychiatry. 1972;27(4):491-499.


Abstract



This article reviews data published in the last decade describing various therapeutic approaches to tardive dyskinesia. A variety of drugs and treatment modalities have been reported to be effective in the short-term treatment of this syndrome. However, no definite effective treatment has been clearly shown to alleviate or reduce tardive dyskinesia symptomatology over a long time period. As long as psychiatrists must administer neuroleptic drugs to psychotic patients for many years, this syndrome will pose a continuing problem. Further search for effective treatments is vitally necessary as is investigation of ways of preventing this distressing iatrogenic complication. The need for standardized diagnostic criteria as well as objective evaluation methods is clear. In view of present ideas about the pathogenesis of this syndrome, the study of the drugs which may deplete dopamine or counteract dopaminergic activity appears most justified and promising.



Author Affiliations



Boston

From Boston State Hospital. Dr. Kazamatsuri is currently at Teikyo University School of Medicine, Tokyo.


Footnotes



Accepted for publication July 3, 1972.

Reprint requests to Boston State Hospital, 591 Morton St, Boston 02124 (Dr. Chien).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience
Jeste and Jed Wyatt
Arch Gen Psychiatry 1982;39:803-816.
ABSTRACT  

Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane and Smith
Arch Gen Psychiatry 1982;39:473-481.
ABSTRACT  

Metoclopramide Treatment of Tardive Dyskinesia
Karp et al.
JAMA 1981;246:1934-1935.
ABSTRACT  

Assessment of Tardive Dyskinesia in Psychiatric Outpatients Using a Standardized Rating Scale
Rey et al.
Aust N Z J Psychiatry 1981;15:33-37.
ABSTRACT  

Tardive Dyskinesia--Reversible and Persistent
Jeste et al.
Arch Gen Psychiatry 1979;36:585-590.
ABSTRACT  

Clinical Psychopharmacology in Its 20th Year
Crane
Science 1973;181:124-128.
 

Neurological Syndromes Associated With Antipsychotic Drug Use: A Special Report
FREEDMAN
Arch Gen Psychiatry 1973;28:463-467.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.